Glucose Noridem (Glucose Monohydrate)

Glucose Noridem is used as part of intravenous therapy to support patients who cannot receive nutrition orally.

• Provides a source of glucose for parenteral nutrition in patients requiring total or supplemental intravenous feeding.
• Treats acute hypoglycemia when rapid elevation of blood glucose is needed.
• Assists in fluid and electrolyte replacement by contributing to osmotic load.
• Supports metabolic needs during perioperative or critical‑care management.
• Can be combined with other intravenous nutrients to formulate customized nutrition admixtures.

Adverse reactions to Glucose Noridem are generally related to the intravenous administration of a glucose solution.

Common

• Local irritation or pain at the infusion site.
• Mild hyperglycemia reflected by transiently elevated blood glucose levels.
• Electrolyte shifts, particularly mild hyponatremia or hypokalemia.
• Nausea or mild gastrointestinal discomfort.

Serious

• Severe hyperglycemia with risk of osmotic diuresis.
• Fluid overload leading to pulmonary edema in susceptible patients.
• Allergic reactions such as urticaria, angioedema, or anaphylaxis.
• Metabolic acidosis in patients with impaired glucose utilization.

When prescribing Glucose Noridem, clinicians should evaluate patient-specific factors and monitor relevant parameters.

• Verify blood glucose levels before and during infusion to avoid excessive hyperglycemia.
• Assess fluid status and cardiac function to prevent volume overload.
• Adjust dosage in patients with renal or hepatic impairment due to altered glucose metabolism.
• Use caution in diabetic patients and those receiving other dextrose-containing solutions.
• Monitor electrolytes, especially sodium and potassium, during prolonged therapy.
• Consider contraindication in patients with known hypersensitivity to glucose monohydrate.

Glucose Noridem may interact with other intravenous agents or systemic medications.

Avoid

• Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring.
• Simultaneous infusion of other hyperosmolar dextrose solutions that could cause severe hyperglycemia.
• Use with medications that significantly raise serum potassium, increasing risk of hyperkalemia.
• Concurrent infusion of sodium bicarbonate solutions, which may increase osmolar load.

Use with caution

• Concurrent administration of diuretics, which may alter fluid balance.
• Combination with corticosteroids, which can exacerbate hyperglycemia.
• Concurrent use of beta‑adrenergic agonists that may affect glucose metabolism.
• Co‑administration with thiazide diuretics, which can impair glucose tolerance.